School of Natural Medicine, Faculty of Community and Health Sciences, Bellville, Cape Town 7535, South Africa.
CREATE Fertility, 150 Cheapside, London EC2V 6ET, UK.
Medicina (Kaunas). 2022 Aug 4;58(8):1047. doi: 10.3390/medicina58081047.
: Male hypogonadism is a clinical disorder characterized by reduced serum testosterone in men. Although treatment using herbal medicines, including has been investigated, the benefits remain unclear. This study aims to investigate the efficacy of as a sole intervention to increase testosterone levels in males. : We conducted a systematic review and meta-analysis of randomized clinical trials (RCTs) according to the PRISMA guidelines. Relevant articles were retrieved from the databases PubMed, Scopus, Web of Science, Cochrane, Ovid/Embase, and Google Scholar. After literature screening, a total of nine studies was included in the systematic review. Five RCTs were included in the meta-analysis. A significant improvement in total testosterone levels after treatment was mostly reported in both healthy volunteers and hypogonadal men. The random model effect revealed a significant increase (SMD = 1.352, 95% CI 0.565 to 2.138, = 0.001) in the total testosterone levels in men receiving supplementation, which was confirmed in the hypogonadism subgroup. : This systematic review and meta-analysis of the literature supports the possible use of supplementation for enhancing testosterone production. Although more research is required before its use in clinical practice, this may represent a safe and promising therapeutic option, particularly in hypogonadal men.
男性性腺功能减退症是一种以男性血清睾酮减少为特征的临床疾病。虽然已经研究了包括 在内的草药治疗方法,但疗效仍不清楚。本研究旨在探讨 作为单一干预措施增加男性睾酮水平的疗效。
我们按照 PRISMA 指南对随机临床试验 (RCT) 进行了系统评价和荟萃分析。从 PubMed、Scopus、Web of Science、Cochrane、Ovid/Embase 和 Google Scholar 数据库中检索相关文章。经过文献筛选,共有 9 项研究纳入系统评价。5 项 RCT 纳入荟萃分析。大多数研究报告,在健康志愿者和性腺功能减退男性中, 治疗后总睾酮水平显著改善。随机效应模型显示,接受 补充剂的男性总睾酮水平显著升高(SMD=1.352,95%CI 0.565 至 2.138, =0.001),在性腺功能减退亚组中也得到了证实。
本系统评价和荟萃分析支持 补充剂可能用于增强睾酮生成。虽然在临床实践中使用之前还需要更多的研究,但这可能代表一种安全且有前途的治疗选择,特别是在性腺功能减退男性中。